MedicarePartD.guide

A non-government resource built from CMS public data

HIV treatment and prevention on Humana Premier Rx Plan (S5884-153)

Biktarvy, Dovato, Descovy and the other common HIV regimens, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Virginia
Premium
$87.60/month
Deductible
None
Change plan

10 of 11 HIV drugs are covered on this plan. None require prior authorization.

1 isn't on the formulary (Truvada).

  • Biktarvy
    bictegravir/emtricitabine/tenofovir alafenamide
    Covered
    from $1,345.58
    Tier 5
  • Dovato
    dolutegravir and lamivudine
    Covered
    $1,040.40
    Tier 5
  • Triumeq
    abacavir/dolutegravir/lamivudine
    Covered
    from $1,199.59
    Tier 4
  • Genvoya
    elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide
    Covered
    $1,408.98
    Tier 5
  • Odefsey
    emtricitabine/rilpivirine/tenofovir alafenamide
    Covered
    $1,283.19
    Tier 5
  • Symtuza
    darunavir/cobicistat/emtricitabine/tenofovir alafenamide
    Covered
    $1,494.04
    Tier 5
  • Juluca
    dolutegravir and rilpivirine
    Covered
    $1,199.94
    Tier 5
  • Descovy
    emtricitabine and tenofovir alafenamide
    Covered
    from $736.88
    Tier 5
  • emtricitabine-tenofovir
    generic Truvada
    Covered
    from $11.35
    Tier 4
  • Tivicay
    dolutegravir
    Covered
    from $455.24
    Tier 5
Not on the formulary
Truvada

Patient cost for a 30-day supply at a preferred retail pharmacy. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list